Clinical Trial

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated December 21, 2025 completion). Its status may not reflect the trial's current state.
Summary
Prospective multicenter study in which all patients with borderline or locally advanced pancreatic adenocarcioma undergoing neoadjuvant chemotherapy and surgical exploration with curative intent will be included for one year. Preoperative images by traditional CT and 3D-MSP technology will be evaluated, comparing the accuracy variables (sensitivity, specificity, predictive values, area under the curve, concordance index) of both techniques with the gold standard (results of surgery and histopathological analysis).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-30.
Trial Details
NCT Number NCT06582342
Lead Sponsor Fundación para la Investigación del Hospital Clínico de Valencia
Conditions Adenocarcinoma of the Pancreas
Enrollment 70 participants
Start Date 2024-03-21
Primary Completion 2025-12-21 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-06